KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GoodRx Holdings (GDRX) Acquisitions (2020 - 2025)

GoodRx Holdings (GDRX) has disclosed Acquisitions for 4 consecutive years, with $13.4 million as the latest value for Q4 2025.

  • Quarterly Acquisitions changed N/A to $13.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $43.4 million through Dec 2025, changed N/A year-over-year, with the annual reading at $43.4 million for FY2025, N/A changed from the prior year.
  • Acquisitions hit $13.4 million in Q4 2025 for GoodRx Holdings, down from $30.0 million in the prior quarter.
  • In the past five years, Acquisitions ranged from a high of $149.9 million in Q2 2022 to a low of $7.0 million in Q1 2022.
  • Historically, Acquisitions has averaged $56.8 million across 3 years, with a median of $22.3 million in 2021.
  • Biggest five-year swings in Acquisitions: crashed 73.94% in 2021 and later increased 19.21% in 2022.
  • Year by year, Acquisitions stood at $14.5 million in 2021, then soared by 930.79% to $149.9 million in 2022, then tumbled by 91.03% to $13.4 million in 2025.
  • Business Quant data shows Acquisitions for GDRX at $13.4 million in Q4 2025, $30.0 million in Q1 2025, and $149.9 million in Q2 2022.